Virtus LifeSci Biotech Products ETF(BBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BBP Virtus LifeSci Biotech Products ETF

休市中 08-14 16:00:00 EDT

101.31

+0.22

+0.22%

盘后101.33

+0.02+0.02%

19:34 EDT

最高101.33	最低99.81	成交量1.12万
今开101.16	昨收101.09	日振幅1.51%
总市值1.06亿	流通市值1.06亿	总股本105.00万
成交额112.49万	换手率1.07%	流通股本105.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":101.3121,"timestamp":1786737600000,"preClose":101.0899,"halted":0,"volume":11194,"hourTrading":{"tag":"盘后","latestPrice":101.33,"preClose":101.3121,"latestTime":"19:34 EDT","volume":10,"amount":1013.5926,"timestamp":1786750447025,"change":0.0179,"changeRate":0.000177,"amplitude":0},"delay":0,"changeRate":0.002198043523635901,"floatShares":1050004,"shares":1050004,"eps":0,"marketStatus":"休市中","change":0.2222,"latestTime":"08-14 16:00:00 EDT","open":101.16,"high":101.33,"low":99.805,"amount":1124904.5375599999,"amplitude":0.015086,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1786953600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":101.0899,"sharesOutstanding":600004,"nav":101.277,"aum":106341029.99,"bidAskSpread":0.002572,"postHourTrading":{"tag":"盘后","latestPrice":101.33,"preClose":101.3121,"latestTime":"19:34 EDT","volume":10,"amount":1013.5926,"timestamp":1786750447025,"change":0.0179,"changeRate":0.000177,"amplitude":0},"volumeRatio":1.0767603027776096,"impliedVol":0.1936,"impliedVolPercentile":0.1713},"requestUrl":"/m/hq/s/BBP/wiki","defaultTab":"wiki","newsList":[{"id":"2659504119","title":"中国银河证券：实验动物为创新药研发刚需 小鼠+猴双主线高景气","url":"https://stock-news.laohu8.com/highlight/detail?id=2659504119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659504119?lang=zh_cn&edition=full","pubTime":"2026-08-14 15:07","pubTimestamp":1786691225,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国银河证券发布研报称，实验动物为创新药研发刚需，行业壁垒深厚，两大细分赛道具备中长期成长逻辑：人源化小鼠赛道成长确定性更强、周期波动平缓;实验猴赛道供给约束强，短期价格上行带来显著业绩弹性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XLVI","IBB","APXH","PBE","LFSC","06881","WRND","BK4585","GDOC","601881","BK4588","GSKH","BIOY","BBP","161027","SBIO","BK1147","BK0188","BK0276","BK1564"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903675","title":"百花医药股价严重异常波动：主营小分子化学仿制药CRO业务 不涉及创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903675","media":"央广财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658903675?lang=zh_cn&edition=full","pubTime":"2026-08-12 21:27","pubTimestamp":1786541220,"startTime":"0","endTime":"0","summary":"8月12日，百花医药（维权）（600721.SH）发布公告称，公司股票连续10个交易日内日收盘价格涨幅偏离值累计超过100%，根据上交所的有关规定，属于股票交易严重异常波动情形。公司是以小分子化学仿制药研发为主的CRO企业，不涉及创新药研发。公司2026年第一季度实现营业收入6718.29万元，同比下降30.68%，归属于上市公司股东的净利润664.27万元，同比下降67.94%。目前公司主营业务未发生重大变化，市场环境、行业政策没有发生重大调整，股价短期内连续上涨，涨幅与公司经营情况严重偏离。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-12/doc-ininamih5206238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SBIO","GSKH","APXH","IBB","BK4588","PBE","XLVI","600721","BIOY","BK4585","GDOC","LFSC","WRND","BK0216","BK0102","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658692990","title":"百花医药(600721.SH)：不涉及创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2658692990","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658692990?lang=zh_cn&edition=full","pubTime":"2026-08-11 20:03","pubTimestamp":1786449780,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["WRND","BIOY","BK4585","SBIO","GSKH","IBB","GDOC","PBE","BBP","LFSC","BK4588","APXH","XLVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658667990","title":"百花医药(600721.SH)：不涉及创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2658667990","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658667990?lang=zh_cn&edition=full","pubTime":"2026-08-11 20:03","pubTimestamp":1786449780,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百花医药(600721.SH)发布股票交易风险提示公告称，公司是以小分子化学仿制药研发为主的CRO企业，主营业务是为客户提供小分子化仿药为主的药物研发注册“一站式”全流程服务，主要研发项目多来自于客户委托加部分的公司自主立项，不涉及创新药研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BIOY","SBIO","GDOC","APXH","XLVI","LFSC","BK0216","BK4588","600721","GSKH","WRND","BK4585","PBE","IBB","BK0102","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658604159","title":"东方证券：AI重构创新药研发底座 国内相关产业链公司亦有望受益","url":"https://stock-news.laohu8.com/highlight/detail?id=2658604159","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658604159?lang=zh_cn&edition=full","pubTime":"2026-08-11 15:29","pubTimestamp":1786433354,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，东方证券发布研报称，随着全球监管转向，AI制药规模应用正快速落地，已从早研工具演进为覆盖研发全链条的端到端体系，有望颠覆创新药研发长周期、高成本、高失败率的“反摩尔定律”。该行认为，海外MNC和科技巨头正在全面拥抱AI，而国内AI制药公司已崭露头角，相关产业链公司亦有望受益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260811/32331495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0188","BK0276","BK1147","XLVI","AGIX","BK0028","SBIO","AIPO","BK4588","QTOC","WRND","PBE","600958","BK0012","BK1564","VTHR","BBP","BK0183","APXH","LFSC","CHAT","BIOY","GDOC","GSKH","ARTY","IBB","BK4585","03958"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193258586","title":"新闻稿：Ernexa Therapeutics 引入资深生物技术高管 David Polinsky 加入董事会，为临床阶段冲刺蓄力","url":"https://stock-news.laohu8.com/highlight/detail?id=1193258586","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193258586?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:09","pubTimestamp":1786367399,"startTime":"0","endTime":"0","summary":"此次任命正值公司关键转折点，进一步强化了其领导团队——Ernexa 正全力推进其核心项目 ERNA-101，计划于2026年第三季度提交新药临床试验申请，并在第四季度启动首项一期临床研究。马萨诸塞州剑桥市，2026年8月10日——Ernexa Therapeutics，一家致力于开发创新细胞疗法以治疗晚期癌症和自身免疫性疾病的行业先锋，今日宣布任命 David Polinsky 为其董事会成员。“我们正步入 Ernexa 历史上最为重要的时期之一，”Ernexa Therapeutics 总裁兼首席执行官 Sanjeev Luther 表示。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","XBI","BK4233","BK4588","LENZ","BK4007","BK4585","BK4139","ERNA","RFL","IND","SYNB","IBB","BBP","BK4205","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656080539","title":"阿斯利康拟与百时美施贵宝4000亿美元重组传闻背后：专利悬崖、产品短板倒逼，AZ端反对声大","url":"https://stock-news.laohu8.com/highlight/detail?id=2656080539","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656080539?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:26","pubTimestamp":1785835565,"startTime":"0","endTime":"0","summary":"蓝鲸新闻记者联系了阿斯利康方面，对方拒绝对此置评。此外，BMS有神经管线与Eliquis后续心血管资产，可补足AZ在相关领域的短板。据BMO资本在研报中指出，两家公司都没有足够的财务实力直接收购对方，预计阿斯利康能掏出约370亿美元，而百时美施贵宝约为320亿美元，远低于搞定一桩价值4000亿美元合并所需的资金。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1785835141389493693","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0128525929.USD","LU1868836591.USD","LU2237443895.HKD","APXH","LU2242646821.SGD","AZNH","IYH","LU0432979614.USD","PPH","RSPH","FHLC","IHE","BMY","LU0321505868.SGD","LU1093756168.USD","LU1585245621.USD","LU2596442595.SGD","PBPH","BME","GSKH","BK4559","TMED","MEDI","LU2089984988.USD","LU0267386448.USD","LU2462157665.USD","LU1868836914.USD","LU1093756325.SGD","PJP","IE00BJJMRZ35.SGD","FTXH","LU0321505439.SGD","LU1868837300.USD","BBP","LU2237443382.USD","AZN","BBH","FXH","BK4588","IE00B2B36J28.USD","LU0882574055.USD","TRUH","JDOC","LU1670710588.SGD","LU1032466523.USD","LU1670711123.USD","AZ","LU0985481810.HKD","LU0225284248.USD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104860953","title":"全球能源市场速览：市场动态简报","url":"https://stock-news.laohu8.com/highlight/detail?id=1104860953","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104860953?lang=zh_cn&edition=full","pubTime":"2026-07-30 21:53","pubTimestamp":1785419602,"startTime":"0","endTime":"0","summary":"0951 ET - 美国天然气期货价格走低，市场正静待美国能源信息署于北京时间10:30发布的周度库存报告。市场普遍预期，数据将显示天然气库存增幅超出常态，从而进一步扩大相对于五年平均水平的盈余。然而，英国央行的声明称，目前几乎没有迹象表明高能源价格会引发第二轮效应，并指出工资增长正在放缓，劳动力市场疲软。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DIVZ","TSL","REGL","UCC","FT","FXD","CDC","PSC","AVSD","TSLL","ARP","TSLQ","BBEU","ILCV","EQRR","ADPV","CGVV","TSLP","XOEX","SDOG","CRSH","FLGB","07366","DECU","LRCY","TSLZ","DHLX","LGH","ISVL","IDEV","TSYY","VDE","LCG","BBP","PEVC","BAMA","VOTE","FITZ","TSLG","09766","IMCG","IUS","RJZ","MAPP","VAW","FLXI","BK4582","TLA","TSLT","KOMP","IJK","AGGZ","TCTL","TSLS","CAOS","CGDV","RULE","TSLW","BKDV","ERX","RHTX","ESLV","FXR","RMIF","TSLO","VTV","TACN","07766","CLIX","LCO","EES","SPCT","FXL","BSR","MODL","TEST","PRVS","DFUV","MDLV","BOE","ANEW","REMC","TEQI","BK4585","TSDD","CGUI","PMDE","NSIV","CGUS","KLCD","TSLI","TSII","SAMT","VXZ","TSLY","09366","FLV","PLGI","BK4588","TSLR","TESL","HIDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654091684","title":"总部位于荷兰阿姆斯特丹的全球生物制药公司 ARGENX将以每股77美元的现金收购FORTE BIOSCIENCES。","url":"https://stock-news.laohu8.com/highlight/detail?id=2654091684","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654091684?lang=zh_cn&edition=full","pubTime":"2026-07-27 13:03","pubTimestamp":1785128639,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MRNY","BBP","MRNX","UUP","UDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653752990","title":"安永：至2028年全球前25大医药企业存在千亿美元增长缺口","url":"https://stock-news.laohu8.com/highlight/detail?id=2653752990","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653752990?lang=zh_cn&edition=full","pubTime":"2026-07-22 19:23","pubTimestamp":1784719424,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IBBQ","BBP","MRNY","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653584157","title":"创新药研发加速遇“猴荒”","url":"https://stock-news.laohu8.com/highlight/detail?id=2653584157","media":"三里河","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653584157?lang=zh_cn&edition=full","pubTime":"2026-07-22 16:21","pubTimestamp":1784708497,"startTime":"0","endTime":"0","summary":"“要站在‘猴’里，不要像猴子一样站在那里。”资本市场从来不缺故事。近期，昭衍新药业绩暴增，原因是实验猴市场价格上涨，带动公司手里的“猴子资产”大幅增值，多家相关概念公司股价也跟风大涨。甚至有人顺藤摸瓜，挖出了“香蕉概念”。网友戏称：这是产业链挖掘最深的一次。一只猴子，为什么能扰动资本市场？答案藏在药物的研发链条里。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607223817277458.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607223817277458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GDOC","APXH","LFSC","BK4585","GSKH","XLVI","BK4588","SBIO","PBE","IBB","BIOY","BBP","WRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651774435","title":"免疫疾病生物制药公司Attovia(ATTO.US)申请在美上市 拟募资1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651774435","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651774435?lang=zh_cn&edition=full","pubTime":"2026-07-15 11:17","pubTimestamp":1784085422,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段生物制药公司Attovia Therapeutics已提交首次公开募股申请，计划募集最多1亿美元资金。该公司计划在纳斯达克上市，股票代码为“ATTO”。　　据悉，Attovia利用其ATTOBODY平台开发用于治疗免疫介导性疾病的生物制剂。Alamar于2023年设立Attovia作为独立公司，以便自身专注于蛋白质组学和疾病检测业务，目前仍是Attovia的重要股东。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260715/32307966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["MRNY","IBBQ","MRNX","BBP","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651435511","title":"免疫疾病生物制药公司Attovia(ATTO.US)申请在美上市 拟募资1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651435511","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651435511?lang=zh_cn&edition=full","pubTime":"2026-07-15 10:45","pubTimestamp":1784083531,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段生物制药公司Attovia Therapeutics已提交首次公开募股申请，计划募集最多1亿美元资金。据悉，Attovia利用其ATTOBODY平台开发用于治疗免疫介导性疾病的生物制剂。自通过IPO融资2.2亿美元以来，Alamar股价已上涨近60%。Alamar于2023年设立Attovia作为独立公司，以便自身专注于蛋白质组学和疾病检测业务，目前仍是Attovia的重要股东。Attovia的核心候选药物ATTO-1310针对白细胞介素-31，目前已完成针对健康志愿者以及患有慢性瘙痒症和特应性皮炎患者的Ⅰ期临床试验给药。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1467668.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBBQ","IPOS","BBP","MRNX","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651435505","title":"免疫疾病生物制药公司Attovia(ATTO.US)申请在美上市 拟募资1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651435505","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651435505?lang=zh_cn&edition=full","pubTime":"2026-07-15 10:45","pubTimestamp":1784083531,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MRNY","BBP","MRNX","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651162210","title":"英硅智能早盘涨超7% 与康哲药业达成AI+创新药研发新合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2651162210","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651162210?lang=zh_cn&edition=full","pubTime":"2026-07-13 10:02","pubTimestamp":1783908120,"startTime":"0","endTime":"0","summary":"　　英硅智能早盘涨超7%，截至发稿，股价上涨6.21%，报45.48港元，成交额3.32亿港元。　　7月13日，据英硅智能官微消息，公司宣布与康哲药业在中枢神经系统领域开展另一项AI驱动的药物发现合作。　　根据合作协议，双方将结合英硅智能已验证的AI平台与AI赋能创新药研发能力，以及康哲药业经验丰富的研发团队和对疾病领域的深度认知，双方共同推进该研发项目的合作开发。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-13/doc-inihrnpk9058117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AGIX","IE00BVYPNQ40.USD","SG9999004220.SGD","SBIO","IE00BYV24P56.USD","BK1593","AIPO","BK1191","BK4588","QTOC","WRND","PBE","00867","VTHR","BBP","SG9999015952.SGD","SG9999015986.USD","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","LFSC","SG9999015945.SGD","CHAT","GDOC","LU2488822045.USD","SG9999015978.USD","GSKH","ARTY","IE00BGHQDM52.EUR","IBB","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649952006","title":"（活力中国调研行）上海生物医药产业规模破万亿 张江药谷青年人才成创新药研发主力","url":"https://stock-news.laohu8.com/highlight/detail?id=2649952006","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649952006?lang=zh_cn&edition=full","pubTime":"2026-07-08 11:56","pubTimestamp":1783482969,"startTime":"0","endTime":"0","summary":"中新网上海7月8日电(杨海燕马佳佳)“我们对青年人才‘如饥似渴’，上海团队有180多名全职员工，90%以上都是40岁以下的青年人才。”英硅智能全球对外合作负责人、副总裁王珏7日在“活力中国调研行”主题采访活动中介绍道。在上海张江药谷，这片曾经的农田已崛起为世界级生物医药创新高地，而活跃其中的青年人才，正成为推动创新药研发的主力军。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607083798154946.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607083798154946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","BK4588","LFSC","PBE","399441","WRND","XBI","161726","BK4581","IBB","SBIO","BBP","GDOC","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984355","title":"翰思艾泰-B(03378)：拟与华科前沿交叉研究中心打造新一代AI驱动的创新药研发范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984355","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649984355?lang=zh_cn&edition=full","pubTime":"2026-07-07 18:57","pubTimestamp":1783421872,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B 发布公告，为充分发挥产学研结合的优势，加速生物医药研发创新，公司于近日与华科—澳城大高等研究院前沿交叉研究中心正式签署了《“人工智能药物研发联合实验室”合作共建协议》。双方将依托华科前沿交叉研究中心的AI平台，以及翰思艾泰在创新药研发的丰富经验和对疾病领域的深度认知，围绕抗体发现与分子设计展开深度合作，共同打造新一代AI驱动的创新药研发范式。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","LFSC","BBP","AGIX","WRND","GDOC","QTOC","GSKH","IBB","03378","CHAT","BK1173","ARTY","BK4588","AIPO","SBIO","VTHR","PBE","BK1535","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679149","title":"生物制药公司Crinetics盘后涨超100%福泰制药将以85美元/股收购公司。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649679149?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:09","pubTimestamp":1783368555,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["UDN","LU2236285917.USD","LU0320765992.SGD","LU2324357040.USD","LU2456880835.USD","LU1674673691.USD","LU1674673428.USD","LU2417539215.USD","BK4567","IE00B19Z3581.USD","IE0002141913.USD","LU1585245621.USD","IBBQ","LU1778281490.HKD","LU0079474960.USD","BK4585","LU2462157665.USD","LU0061475181.USD","BK4588","BBP","LU0289739699.SGD","LU2362540622.SGD","IE00B19Z9P08.USD","IDNA","BK4533","LU0823416689.USD","LU1093756168.USD","LU2362541513.USD","UUP","IE00BJJMRZ35.SGD","MRNY","PBE","VRTX","BK4532","MRNX","SGXZ57979304.SGD","BBH","IE00B19Z9Z06.USD","LU1035775433.USD","BK4139","LU2237438978.USD","IBB","IE00BJT1NW94.SGD","LU2362541273.HKD","SG9999013999.USD","LU1093756325.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","SG9999001176.USD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625984433","title":"河北省市监局：13类产品抽检74批次不合格，涉贵金属饰品、成品油等","url":"https://stock-news.laohu8.com/highlight/detail?id=2625984433","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2625984433?lang=zh_cn&edition=full","pubTime":"2026-04-07 13:22","pubTimestamp":1775539336,"startTime":"0","endTime":"0","summary":"针对问题产品，监管部门已责成属地市场监管部门依法处理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1775538842223186739","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["DBP","BK4220","IE00B1B80R65.USD","BV","BBP","BK4103","BK4120","BK4172","BK4588","BK4585","DEHP","SBS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0317},{"period":"3month","weight":0.1805},{"period":"6month","weight":0.25},{"period":"1year","weight":0.5196},{"period":"ytd","weight":0.2677}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0503},{"period":"6month","weight":0.1387},{"period":"1year","weight":0.2037},{"period":"ytd","weight":0.1385}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.013251},{"month":2,"riseRate":0.416667,"avgChangeRate":0.009089},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010237},{"month":4,"riseRate":0.583333,"avgChangeRate":0.00248},{"month":5,"riseRate":0.583333,"avgChangeRate":0.009273},{"month":6,"riseRate":0.916667,"avgChangeRate":0.050034},{"month":7,"riseRate":0.666667,"avgChangeRate":0.017627},{"month":8,"riseRate":0.666667,"avgChangeRate":0.022041},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.015494},{"month":10,"riseRate":0.636364,"avgChangeRate":-0.014134},{"month":11,"riseRate":0.909091,"avgChangeRate":0.065286},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.005253}],"exchange":"ARCA","name":"Virtus LifeSci Biotech Products ETF","nameEN":"Virtus LifeSci Biotech Products ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Virtus LifeSci Biotech Products ETF(BBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Virtus LifeSci Biotech Products ETF(BBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Virtus LifeSci Biotech Products ETF,BBP,Virtus LifeSci Biotech Products ETF股票,Virtus LifeSci Biotech Products ETF股票老虎,Virtus LifeSci Biotech Products ETF股票老虎国际,Virtus LifeSci Biotech Products ETF行情,Virtus LifeSci Biotech Products ETF股票行情,Virtus LifeSci Biotech Products ETF股价,Virtus LifeSci Biotech Products ETF股市,Virtus LifeSci Biotech Products ETF股票价格,Virtus LifeSci Biotech Products ETF股票交易,Virtus LifeSci Biotech Products ETF股票购买,Virtus LifeSci Biotech Products ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Virtus LifeSci Biotech Products ETF(BBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Virtus LifeSci Biotech Products ETF(BBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}